Management of Hypertension in Diabetes
- Barry Stults, MD and
- Robert E. Jones, MD, FACP, FACE
Abstract
In Brief
Untreated or poorly controlled hypertension can significantly accelerate the development and progression of both the micro- and macrovascular complications of diabetes. Aggressive blood pressure control improves patient outcomes and reduces health care costs. Unfortunately, nearly two-thirds of people with diabetes do not have blood pressure readings within the target range. Effective antihypertensive regimens maximize nonpharmacological therapies, minimize adverse effects on glucose control, lessen the risk of medication-related side-effects, and provide adequate cardiac and renal protection.
Footnotes
-
Barry Stults, MD, is a professor of medicine, and Robert E. Jones, MD, FACP, FACE, is an adjunct associate professor of medicine at the University of Utah School of Medicine in Salt Lake City.
-
Note of disclosure: Dr. Stults has received honoraria for speaking engagements from and has served as a consultant to Pfizer, and Dr. Jones is employed by Sanofi-Aventis Group. Both companies manufacture pharmaceutical products for the treatment of hypertension.
- American Diabetes Association
